Answers are grounded in this paper and cite their sources.
Objective The aim of the study was to determine the prognostic ability of urinary liver-type fatty acid-binding protein (L-FABP) and to further characterize its sensitivity and specificity as a biomarker of acute kidney injury (AKI). Patients and methods This case–control study was carried out on 42 septic neonates who developed AKI of the 60 critically ill neonates admitted to Neonatal Intensive Care Unit of Al-Zahraa Hospital. Urine L-FABP at the time of ICU admission was quantitated to be compared with serum creatinine at admission and after 48 h. Results AKI patients showed significantly higher level of urinary L-FABP than non-AKI patients. The diagnostic performance, assessed by the area under the receiver operating characteristic curve, was 0.743 for L-FABP, demonstrating its usefulness in diagnosing AKI. Conclusion Urinary L-FABP seems to be promising both for the diagnosis of AKI and for the prediction of prognosis in heterogeneous ICU patients. It needs to be further validated for clinical utility.
No takes yet. Share an insight, caveat, or question.
Elnady et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: